Cite

1. Williams DM. Clinical Pharmacology of Corticosteroids. Respir Care. 2018;63(6):655-670.10.4187/respcare.0631429794202 Search in Google Scholar

2. Alan IS, Alan B. Side Effects of Glucocorticoids. In: Malangu N, editor. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. London: IntechOpen; 2017. p. 93-124.10.5772/intechopen.72019 Search in Google Scholar

3. Stanbury RM, Graham EM. Systemic corticosteroid therapy-side effects and their management. Br J Ophthalmol. 1998;82(6):704-8.10.1136/bjo.82.6.70417226229797677 Search in Google Scholar

4. Hougardy DM, Peterson GM, Bleasel MD, Randall CT. Is enough attention being given to the adverse effects of corticosteroid therapy. Journal of Clinical Pharmacy and Therapeutics. 2000;25(3):227-234.10.1046/j.1365-2710.2000.00284.x10886467 Search in Google Scholar

5. McDougall D, Bhibhatbhan A, Toth C. Adverse effects of corticosteroid therapy in neuromuscular diseased patients are common and receive insufficient prophylaxis. Acta Neurol Scand. 2009;120(5):364-7.10.1111/j.1600-0404.2009.01190.x19832774 Search in Google Scholar

6. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14(1):2029-2049.10.2147/TCRM.S138000622590730464484 Search in Google Scholar

7. Rees A, Levy M, Lansdown A. Clinical endocrinology and diabetes at a glance. 1st ed. Hoboken: Wiley; 2017. Search in Google Scholar

8. Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7-16.10.1007/s12020-018-1588-2599711629691807 Search in Google Scholar

9. Sheu A, Diamond T. Bone mineral density: testing for osteoporosis. Australian prescriber. 2016;39(2):35-39.10.18773/austprescr.2016.020491763527340320 Search in Google Scholar

10. WHO Scientific Group on the assessment of osteoporosis at primary health care level. Summary meeting report. Brussels: World Health Organization.; 2004. p.1-17. Search in Google Scholar

11. Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, Van K, Hyun D. Osteoporosis: A Review of Treatment Options. P T. 2018;43(2):92-104. Search in Google Scholar

12. Peng YL, Hu HY, Luo JC, Hou MC, Lin HC, Lee FY. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study. Osteoporos Int. 2014;25(5):1617-23.10.1007/s00198-014-2647-z24566586 Search in Google Scholar

13. Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ. Teriparatide for osteoporosis: importance of the full course. Osteoporos Int. 2016;27(8):2395-410.10.1007/s00198-016-3534-6494711526902094 Search in Google Scholar

14. Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357(20):2028-39.10.1056/NEJMoa071408 Search in Google Scholar

15. Joseph RM, Hunter AL, Ray DW, Dixon WG. Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review. Semin Arthritis Rheum. 2016;46(1):133-41.10.1016/j.semarthrit.2016.03.001 Search in Google Scholar

16. Ospina NS, Al Nofal A, Bancos I, Javed A, Benkhadra K, Kapoor E, Lteif AN, Natt N, Murad MH. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2016 Fe;101(2):427-34.10.1210/jc.2015-1700 Search in Google Scholar

17. Morris D. Steroid-induced diabetes and hyperglycaemia. Part 1: mechanisms and risks. Diabetes & Primary Care. 2018;20(4):151-3. Search in Google Scholar

18. Ginzler EM, Aranow C. 7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus. Baillière’s Clinical Rheumatology. 1998;12(3):495-510.10.1016/S0950-3579(98)80032-0 Search in Google Scholar

19. Satyanarayanasetty D, Pawar K, Nadig P, Haran A. Multiple Adverse Effects of Systemic Corticosteroids: A Case Report. J Clin Diagn Res. 2015;9(5):FD01-2. Search in Google Scholar

20. Khurshid HF, Zikria S, Hamid S, Kumar VA. Self-Medication of Corticosteroids: A Life Threatening Case Report from Pakistan. Journal of Pharmacy Practice and Community Medicine. 2016;2(3):96-9.10.5530/jppcm.2016.3.7 Search in Google Scholar

eISSN:
2285-7079
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine